Bionano Genomics Inc
BNGO
Market Cap$11.07M
Close$
$1.11
66.2% downside
Current Fair Value
66.2% downsideOvervalued by 66.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.07 Million |
|---|---|
| Enterprise Value | $32.42 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-60.05 |
| Beta | 2.28 |
| Outstanding Shares | 2,694,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.11 |
|---|---|
| PEG | 0.12 |
| Price to Sales | 0.33 |
| Price to Book Ratio | 0.19 |
| Enterprise Value to Revenue | 1.14 |
| Enterprise Value to EBIT | -0.35 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.77 |
| Debt to Equity | 0.52 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bionano Genomics Inc
147 employees
CEO: R. Erik Holmlin